Stockreport
Earnings Preview: What To Expect From Incyte's Report [Yahoo! Finance]
Last incyte corporation earnings: 2/13 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations: incyte.com/ir/investor-overview.aspx
of innovative therapeutics across the United States, Europe, Canada, and Japan. It markets a diverse portfolio of oncology, immunology, and dermatology medicines, including JAKAFI, OPZELURA, and ICLUSIG. The Wilmington, Delaware-based company is set to unveil its fiscal Q4 2025 results soon. Ahead of this event, analysts expect INCY to report a profit of $1.66 per share, up 52.3% from $1.09 per share in the year-ago quarter. It has surpassed Wall Street's bottom-line estimates in three of the past four quarters while missing on another occasion. As Trump Says He Is ‘Proud' of Intel, Should You Buy INTC Stock? As SanDisk Eyes Doubling Memory Prices, Should You Buy Red-Hot SNDK Stock? As Netflix Drops 33%, Is NFLX Stock Buy Ahead of Q4 Earnings? Stop Missing Market Moves: Get the FREE Barchart Brief – your midday dose of stock movers, trending sectors, and actionable trade ideas, delivered right to your inbox. Sign Up Now! For fiscal 2025, analysts forecast the specialty dru
[Read more]
| IMPACT SNAPSHOT | EVENT TIME: | INCY | ||||
|---|---|---|---|---|---|---|
|
Last Price
|
Price Change
|
Price Change %
|
Volume Shares
|
Max Up
|
Max Down
|
Volume Ratio
%
|
Performance comparison
Updated
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| LAST PRICE | ||
| VWAP | ||
|
High:
|
MAX UP |
High:
|
|
Low:
|
MAX DOWN |
Low:
|
|
%
|
POST NEWS RANGE |
%
|
|
|
PRICE CHANGE |
|
|
|
PRICE CHANGE PERCENTAGE |
|
|
|
S&P 500 (SPX) |
|
|
%
|
VOLUME RATIO |
%
|
| VOLUME (SHARES) | ||
| TICKS | ||
|
|
AVG SHARES PER TRADE |
|
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Be the first to know
Opt in for alerts from News Quantifed
Opt-in for
INCY alerts
INCY alerts
from News Quantified
Movers & Shakers
The biggest gainers and losers and WHY it moved
INCY alerts
High impacting Incyte Corporation news events
Weekly update
A roundup of the hottest topics
INCY
NEWS
NEWS
- Incyte: Buy For The Turnaround, Stay For The Pipeline [Seeking Alpha][Seeking Alpha]
- Incyte's Pipeline Potential Signals Massive Upside For Investors [Seeking Alpha][Seeking Alpha]
- Factbox-Pharma sector doubles down on AI amid hopes of slashing costs, timelines [Yahoo! Finance][Yahoo! Finance]
- Why Incyte (INCY) Stock Is Trading Up Today [Yahoo! Finance][Yahoo! Finance]
- Incyte CEO Bill Meury: Blood cancer therapy development is company's central identity [CNBC][CNBC]
- More
INCY
SEC Filings
SEC Filings
- 1/8/26 - Form 4
- 1/7/26 - Form 4
- 1/7/26 - Form 144
- INCY's page on the SEC website
- More